TY  - GEN
AU  - Liu,Yong
AU  - Lang,Yunhui
AU  - Patel,Narendra Kumar
AU  - Ng,Grace
AU  - Laufer,Radoslaw
AU  - Li,Sze-Wan
AU  - Edwards,Louise
AU  - Forrest,Bryan
AU  - Sampson,Peter B
AU  - Feher,Miklos
AU  - Ban,Fuqiang
AU  - Awrey,Donald E
AU  - Beletskaya,Irina
AU  - Mao,Guodong
AU  - Hodgson,Richard
AU  - Plotnikova,Olga
AU  - Qiu,Wei
AU  - Chirgadze,Nickolay Y
AU  - Mason,Jacqueline M
AU  - Wei,Xin
AU  - Lin,Dan Chi-Chia
AU  - Che,Yi
AU  - Kiarash,Reza
AU  - Madeira,Brian
AU  - Fletcher,Graham C
AU  - Mak,Tak W
AU  - Bray,Mark R
AU  - Pauls,Henry W
TI  - The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as Anticancer Agents
SN  - 1520-4804
PY  - 2015///0629
KW  - Administration, Oral
KW  - Animals
KW  - Cell Cycle Proteins
KW  - antagonists & inhibitors
KW  - Cell Line, Tumor
KW  - Colon
KW  - drug effects
KW  - Colonic Neoplasms
KW  - drug therapy
KW  - Crystallography, X-Ray
KW  - Female
KW  - Humans
KW  - Indazoles
KW  - administration & dosage
KW  - Mice, Nude
KW  - Models, Molecular
KW  - Protein Kinase Inhibitors
KW  - Protein Serine-Threonine Kinases
KW  - Protein-Tyrosine Kinases
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S
UR  - https://doi.org/10.1021/jm501740a
ER  -